We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$189M
2
GGP
GGP Inc.
GGP
+$166M
3
KRC icon
Kilroy Realty
KRC
+$93.2M
4
ESRT icon
Empire State Realty Trust
ESRT
+$92.1M
5
EPR icon
EPR Properties
EPR
+$59.2M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
1126
Pacific Biosciences
PACB
$422M
$2K ﹤0.01%
642
– –
RIGL icon
1127
Rigel Pharmaceuticals
RIGL
$680M
$2K ﹤0.01%
81
– –
SVRA icon
1128
Savara
SVRA
$1.13B
$2K ﹤0.01%
169
– –
VCYT icon
1129
Veracyte
VCYT
$4.52B
$2K ﹤0.01%
188
– –
PETQ
1130
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
73
– –
MRNS
1131
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
56
– –
NSTG
1132
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
140
– –
PRTK
1133
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
173
– –
CNCE
1134
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
– –
NH
1135
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
40
– –
ACHN
1136
DELISTED
Achillion Pharmaceuticals
ACHN
$2K ﹤0.01%
762
– –
SNNA
1137
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$2K ﹤0.01%
113
– –
AKAO
1138
DELISTED
Achaogen Inc
AKAO
$2K ﹤0.01%
234
– –
SGYP
1139
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
1,363
– –
CORI
1140
DELISTED
Corium International, Inc.
CORI
$2K ﹤0.01%
198
– –
PDLI
1141
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
853
– –
ARDX icon
1142
Ardelyx
ARDX
$1.24B
$1K ﹤0.01%
263
– –
AVDL
1143
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
227
– –
CLLS
1144
Cellectis
CLLS
$286M
$1K ﹤0.01%
49
– –
CRVS icon
1145
Corvus Pharmaceuticals
CRVS
$1.1B
$1K ﹤0.01%
116
– –
FBRX icon
1146
Forte Biosciences
FBRX
$1.12B
– –
0
– –
IBRX icon
1147
ImmunityBio
IBRX
$7.44B
$1K ﹤0.01%
439
– –
NXPI icon
1148
CALL
NXP Semiconductors
NXPI
$68B
$1K ﹤0.01%
+20
New +$2.21K
PGEN icon
1149
Precigen
PGEN
$1.93B
$1K ﹤0.01%
+100
New +$1.69K
SNDX icon
1150
Syndax Pharmaceuticals
SNDX
$1.84B
$1K ﹤0.01%
135
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.